Palisade Bio, Inc. Common Stock (PALI) is a publicly traded Healthcare sector company. As of May 21, 2026, PALI trades at $1.86 with a market cap of $314.54M and a P/E ratio of -6.08. PALI moved +4.42% today. Year to date, PALI is -10.48%; over the trailing twelve months it is +155.12%. Its 52-week range spans $0.53 to $4.32. Analyst consensus is strong buy with an average price target of $10.67. Rallies surfaces PALI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Palisade Bio, Inc. Common Stock (PALI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PALI moved +4.42% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1.86 |
| Market Cap | $314.54M |
| P/E Ratio | -6.08 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.32 |
| 52-Week Low | $0.53 |
| Volume | 3.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.78M |
| Gross Margin | 0.00% |
6 analysts cover PALI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.67.